We are live on
!
Find out more
RSS
Rosenblum Silverman Sutton Portfolio holdings
AUM
$382M
1-Year Est. Return
13.82%
This Fund
S&P 500
This Quarter
Est. Return
+14.37%
1 Year Est. Return
+13.82%
3 Year Est. Return
+95.36%
5 Year Est. Return
+122.03%
10 Year Est. Return
+858.24%
AUM
$236M
AUM Growth
+$24.9M
(+12%)
Cap. Flow
-$311K
Cap. Flow
% of AUM
-0.13%
Top 10 Holdings %
Top 10 Hldgs %
39.67%
Holding
68
New
5
Increased
16
Reduced
36
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
+$3.15M |
| 2 |
Celanese
CE
|
+$2.96M |
| 3 |
Citizens Financial Group
CFG
|
+$2.34M |
| 4 |
Atkore
ATKR
|
+$1.97M |
| 5 |
ON Semiconductor
ON
|
+$1.75M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
American International
AIG
|
+$4.26M |
| 2 |
Gilead Sciences
GILD
|
+$3.28M |
| 3 |
NVIDIA
NVDA
|
+$1.36M |
| 4 |
WOOF
VCA Inc.
WOOF
|
+$1.1M |
| 5 |
American Tower
AMT
|
+$568K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.54% |
| 2 | Consumer Discretionary | 14.93% |
| 3 | Healthcare | 14.2% |
| 4 | Communication Services | 13.49% |
| 5 | Financials | 12.15% |
Similar funds
STP
LWM
DSA
RC
NFP
MADR
MVP
BFP
Rosenblum Silverman Sutton's Q1 2017 Portfolio in Review
As of Q1 2017, Rosenblum Silverman Sutton held 68 positions worth $236M, up 12% from $211M the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Rosenblum Silverman Sutton's Q1 2017 filing shows 5 new, 16 increased, 36 reduced and 5 closed positions. Its largest new stake was Portola Pharmaceuticals, Inc.: 98,785 shares worth $3.87M. The largest sale was American International, an estimated $4.26M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Rosenblum Silverman Sutton's largest Q1 2017 buy was Portola Pharmaceuticals, Inc.: 98,785 shares worth $3.87M.
- Rosenblum Silverman Sutton added most to Celanese in Q1 2017, an estimated $2.96M increase.
- Rosenblum Silverman Sutton's biggest Q1 2017 reduction was Gilead Sciences, cutting an estimated $3.28M.
- Rosenblum Silverman Sutton fully exited American International in Q1 2017, selling an estimated $4.26M.
- Rosenblum Silverman Sutton's ten largest holdings make up 40% of its $236M portfolio in Q1 2017.
- Rosenblum Silverman Sutton opened 5 new positions and closed 5 in Q1 2017.
- Rosenblum Silverman Sutton's portfolio value rose 12% quarter-over-quarter to $236M.
Based on Rosenblum Silverman Sutton's 13F filing for Q1 2017, filed 12 May 2017.